Skip to content

Autologous fat transfer: introduction of a full breast reconstructive method

Autologous fat transfer: introduction of a full breast reconstructive method - BREAST-II

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON55230
Enrollment
350
Registered
2020-01-29
Start date
2020-12-09
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast reconstruction breast reconstructive surgery Breast reconstruction using lipofilling

Interventions

Sponsors

Maastricht Universitair Medisch Centrum +
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Female gender - Age of 18 years and older - History or in candidate for a mastectomy procedure in the near future - Patients undergoing preventive mastectomy - Patients* choice to undergo a breast reconstruction - Wanting to participate in this study - Patient is able to wear the external expansion device

Exclusion criteria

Exclusion criteria: - Active smoker or a history of smoking 4 weeks prior to surgery - Current substance abuse - History of lidocaine allergy - History of silicone allergy - 4 weeks or less after chemotherapy - History of radiation therapy in the breast region - Oncological treatment includes radiotherapy after mastectomy - Kidney disease - Steroid dependent asthma (daily or weekly) or other diseases - Immune-suppressed or compromised disease - Uncontrolled diabetes - BMI>30 - Large breast size (i.e. larger than cup C), unless the patient prefers reduction of the contralateral side towards Cup C - Extra-capsular silicone leaking from the encapsulated implant from a previous breast reconstruction - The treating plastic surgeon has strong doubts on the patient*s treatment compliance

Design outcomes

Primary

MeasureTime frame
The patients* quality of life will be the main outcome measure of this study, using the BREAST-Q questionnaire.

Secondary

MeasureTime frame
The quality of the breast reconstruction will be measured by the volume and shape over time (3D photography or MRI), patient satisfaction (questionnaire) and aesthetic judgement (panel rating pre- and post operative photos). Complications during treatment and follow-up will be registered and compared. Oncological follow-up will be studied, with patients undergoing imaging over a period of 5 years. At last, a cost-effectiveness analysis will be performed to research the economic characteristics of this new technique.

Countries

Netherlands

Contacts

Public ContactW.B.W. Venne

Maastricht Universitair Medisch Centrum +

wessel.vander.venne@mumc.nl+31(0)43-3875469

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026